Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$467,888
-$18,224 QoQ
Shares Held
58,413
-3.5% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 209 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Derivatives in SPRY

reported options exposure · as of Jun 30, 2026
CallValue
$922,752
CallShares
115,200
PutValue
$474,192
PutShares
59,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. SPRY ranks #165 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in SPRY

Export CSV
48 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $467,888 58,413
2026-06-30 $474,192 59,200
2026-06-30 $922,752 115,200
2026-03-31 $1,158,729 144,300
2026-03-31 $408,727 50,900
2026-03-31 $486,112 60,537
2025-12-31 $1,301,305 111,700
2025-12-31 $2,642,220 226,800
2025-09-30 $2,868,270 285,400
2025-09-30 $2,616,015 260,300
2025-06-30 $1,031,295 59,100
2025-06-30 $2,176,015 124,700
2025-06-30 $4,484,056 256,966
2025-03-31 $398,786 31,700
2025-03-31 $2,568,848 204,201
2025-03-31 $728,382 57,900
2024-12-31 $1,808,111 171,385
2024-12-31 $576,030 54,600
2024-12-31 $899,915 85,300
2024-09-30 $2,135,719 147,291
2024-09-30 $3,591,650 247,700
2024-09-30 $2,669,450 184,100
2024-06-30 $8,555,954 1,005,400
2024-06-30 $285,936 33,600
2024-06-30 $217,013 25,501
2024-03-31 $2,305,632 225,600
2024-03-31 $826,235 80,845
2023-12-31 $952,424 173,800
2023-12-31 $177,004 32,300
2023-12-31 $1,388,719 253,416
2023-09-30 $901,530 238,500
2023-09-30 $428,274 113,300
2023-09-30 $663,552 175,543
2023-06-30 $217,750 32,500
2023-06-30 $1,014,112 151,360
2023-03-31 $2,037,330 312,954
2023-03-31 $1,355,382 208,200
2023-03-31 $91,140 14,000
2022-12-31 $391,919 45,946
2022-12-31 $1,661,644 194,800
2022-09-30 $569,184 107,800
2022-09-30 $867,504 164,300
2022-06-30 $642,707 151,582
2022-06-30 $1,504,352 354,800
2022-06-30 $532,968 125,700
2022-03-31 $145,314 41,400
2021-12-31 $406,260 61,000
2021-09-30 $135,728 13,600